nemolizumab-ilto 30 MG Auto-Injector

RxCUI: 2691325
RxNorm name: nemolizumab-ilto 30 MG Auto-Injector
Display name: nemolizumab-ilto 30 MG Auto-Injector
Full name: nemolizumab-ilto 30 MG Auto-Injector
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761390	Nemluvio	nemolizumab-ilto	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NEMLUVIO	NEMOLIZUMAB-ILTO	Galderma Laboratories, L.P.	e9229ef1-ac60-4c24-afb6-009d3c781687	2025-06-26	Warnings, Adverse reactions	Exact identifier rxcui: 2691325

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e9229ef1-ac60-4c24-afb6-009d3c781687	nemolizumab-ilto 30 MG Auto-Injector [PSN] · nemolizumab-ilto 30 MG Auto-Injector [SCD]	2	5	These highlights do not include all the information needed to use NEMLUVIO safely and effectively. See full prescribing information for NEMLUVIO. NEMLUVIO ® (nemolizumab-ilto) for injection, for subcutaneous use Initial U.S. Approval: 2024	20250626